SIRT6 and cholestasis: Therefore, during the administration of SIRT6 agonists for cholestasis treatment, it is beneficial to moderately increase the population of bile-acid-metabolizing bacteria and maintain intestinal flora balance, as this may increase the efficacy of the agonists and lessen potential adverse effects.